University of Surrey

Test tubes in the lab Research in the ATI Dance Research

Current strategies for identifying and validating targets for new treatment-shortening drugs for TB

Williams, KJ and Duncan, K (2007) Current strategies for identifying and validating targets for new treatment-shortening drugs for TB CURRENT MOLECULAR MEDICINE, 7 (3). pp. 297-307.

Full text not available from this repository.
Item Type: Article
Authors :
NameEmailORCID
Williams, KJk.j.williams@surrey.ac.ukUNSPECIFIED
Duncan, KUNSPECIFIEDUNSPECIFIED
Date : 1 May 2007
Identification Number : https://doi.org/10.2174/156652407780598575
Uncontrolled Keywords : Science & Technology, Life Sciences & Biomedicine, Medicine, Research & Experimental, Research & Experimental Medicine, MEDICINE, RESEARCH & EXPERIMENTAL, tuberculosis, drug discovery, essential gene, target validation, MYCOBACTERIUM-TUBERCULOSIS H37RV, STRUCTURAL GENOMICS CONSORTIUM, GENE-EXPRESSION PROFILES, IN-VITRO, MDR-TB, NITROIMIDAZOPYRAN PA-824, CRYSTALLIZATION FACILITY, TRANSPOSON MUTAGENESIS, PULMONARY TUBERCULOSIS, CONDITIONAL EXPRESSION
Related URLs :
Depositing User : Symplectic Elements
Date Deposited : 17 May 2017 10:37
Last Modified : 17 May 2017 14:51
URI: http://epubs.surrey.ac.uk/id/eprint/828505

Actions (login required)

View Item View Item

Downloads

Downloads per month over past year


Information about this web site

© The University of Surrey, Guildford, Surrey, GU2 7XH, United Kingdom.
+44 (0)1483 300800